[14C]-DC-806
- Generic Name
- [14C]-DC-806
Mass Balance and Pharmacokinetics (PK) of [14C]-DC-806 in Healthy Male Participants
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
- Target Recruit Count
- 8
- Registration Number
- NCT06045000
- Locations
- 🇳🇱
ICON Phase 1 Clinic, Groningen, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath